Balchem Corporation

Fundamentals7.0
Price Action4.0
News Sentiment5.0
AI Rating
6.0

Key Drivers

  • Strong Cash Flow
  • Low Leverage
  • Rising Inventory

AI
AI Summary

6.0

BCPC is a high-quality health-and-nutrition specialty-ingredients compounder with strong margins, cash flow, and low leverage, but at ~20x EBITDA and ~32.5x earnings investors should wait for evidence that organic demand and inventory growth support durable pricing power before adding exposure.

QualityCompounder
ValuationRisk
DemandValidation‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

7.0

Key Financial Insights:

  • •Strong Cash Flow
  • •Low Leverage
  • •Rising Inventory

BCPC is financially strong with solid profitability, liquidity, cash flow, and low leverage, but elevated intangibles, rising inventory, and a premium valuation warrant caution.

StrongCash
RichValuation

Price Behavior

4.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • •Lower highs
  • •Support test
  • •Oversold rebound

BCPC remains in a last-month downtrend, but oversold momentum near $164–165 support may support a bounce if it clears $170–172; a break below support would worsen the outlook.

Cautious
Watchlist
Support Level: $164–165
Resistance Level: $170–172

Uneven rebound from $164.39 to $167.05 suggests fragile stabilization

Sentiment & News

5.0

Key News Insights:

  • •Conference participation
  • •September 23 event
  • •No material updates

Balchem will present at the Wells Fargo Consumer Conference on September 23, a neutral investor-relations update with no operational or earnings implications.

InvestorConference

The announcement is unlikely to materially affect Balchem's near-term valuation or trading outlook